Veracyte (NASDAQ: VCYT) reported Q1 EPS of $0.31, $0.29 better than the analyst estimate of $0.02. Revenue for the quarter came in at $114.47 million versus the consensus estimate of $111.14 million.

GUIDANCE:

Veracyte sees FY2025 revenue of $470-480 million, versus the consensus of $488.3 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.